Launoy G - Search Results

1

Proportion and stage distribution of screen-detected and non-screen-detected colorectal cancer in nine European countries: an international, population-based study.

Cardoso R, Guo F, Heisser T, De Schutter H, Van Damme N, Nilbert MC, Tybjerg AJ, Bouvier AM, Bouvier V, Launoy G, Woronoff AS, Cariou M, Robaszkiewicz M, Delafosse P, Poncet F, Walsh PM, Senore C, Rosso S, Lemmens VEPP, Elferink MAG, Tomšič S, Žagar T, Lopez de Munain Marques A, Marcos-Gragera R, Puigdemont M, Galceran J, Carulla M, Sánchez-Gil A, Chirlaque MD, Hoffmeister M, Brenner H. Cardoso R, et al. Among authors: launoy g. Lancet Gastroenterol Hepatol. 2022 Aug;7(8):711-723. doi: 10.1016/S2468-1253(22)00084-X. Epub 2022 May 11. Lancet Gastroenterol Hepatol. 2022. PMID: 35561739

2

[Mass screening for colorectal cancer in France. Experience in 165,000 people in the department of Calvados].

Launoy G, Herbert C, Vallée JP, Desoubeaux N, Réaud JM, Ollivier V, Bouvier V, Flachs A, Arsène D, Valla A, Gignoux M. Launoy G, et al. Gastroenterol Clin Biol. 1996;20(3):228-36. Gastroenterol Clin Biol. 1996. PMID: 8763059 French.

3

Colorectal cancer mass-screening: estimation of faecal occult blood test sensitivity, taking into account cancer mean sojourn time.

Launoy G, Smith TC, Duffy SW, Bouvier V. Launoy G, et al. Int J Cancer. 1997 Oct 9;73(2):220-4. doi: 10.1002/(sici)1097-0215(19971009)73:2<220::aid-ijc10>3.0.co;2-j. Int J Cancer. 1997. PMID: 9335446 Free article.

4

Re: Fecal occult blood screening in the Minnesota study.

Launoy G, Duffy SW, Prevost TC, Bouvier V. Launoy G, et al. J Natl Cancer Inst. 1998 Mar 18;90(6):465-7. doi: 10.1093/jnci/90.6.465-a. J Natl Cancer Inst. 1998. PMID: 9521173 No abstract available.

5

[Mass screening of colorectal cancer by general practitioners in France: what is the real target population?].

Desoubeaux N, Herbert C, Launoy G, Vallée JP, Bouvier V, Maurel J, Née E, Gignoux M. Desoubeaux N, et al. Among authors: launoy g. Gastroenterol Clin Biol. 1997;21(10):760-3. Gastroenterol Clin Biol. 1997. PMID: 9587517 Free article. French.

6

[Detection of cancer, sensitivity of the test and sensitivity of the screening program].

Launoy G, Duffy SW, Prevost TC, Bouvier V. Launoy G, et al. Rev Epidemiol Sante Publique. 1998 Nov;46(5):420-6. Rev Epidemiol Sante Publique. 1998. PMID: 9864771 French.

7

Colorectal cancer after a negative Haemoccult II test and programme sensitivity after a first round of screening: the experience of the Department of Calvados (France).

Bouvier V, Launoy G, Herbert C, Lefevre H, Maurel J, Gignoux M. Bouvier V, et al. Among authors: launoy g. Br J Cancer. 1999 Sep;81(2):305-9. doi: 10.1038/sj.bjc.6990692. Br J Cancer. 1999. PMID: 10496357 Free PMC article.

8

Stage of extension and treatment for colorectal cancer after a negative test and among non-responders in mass screening with guaiac faecal occult blood test: a French experience.

Bouvier V, Herbert C, Lefevre H, Launoy G. Bouvier V, et al. Among authors: launoy g. Eur J Cancer Prev. 2001 Aug;10(4):323-6. doi: 10.1097/00008469-200108000-00005. Eur J Cancer Prev. 2001. PMID: 11535874

9

Cost-effectiveness analysis of two strategies for mass screening for colorectal cancer in France.

Berchi C, Bouvier V, Réaud JM, Launoy G. Berchi C, et al. Among authors: launoy g. Health Econ. 2004 Mar;13(3):227-38. doi: 10.1002/hec.819. Health Econ. 2004. PMID: 14981648

10

Cost of diagnostic and therapeutic management of colorectal cancer according to stage at diagnosis in the Calvados Département, France.

Bouvier V, Reaud JM, Gignoux M, Launoy G. Bouvier V, et al. Among authors: launoy g. Eur J Health Econ. 2003;4(2):102-6. doi: 10.1007/s10198-002-0160-3. Eur J Health Econ. 2003. PMID: 15609176

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

315 results

Search Page